1. Home
  2. KWR vs ANIP Comparison

KWR vs ANIP Comparison

Compare KWR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KWR
  • ANIP
  • Stock Information
  • Founded
  • KWR 1918
  • ANIP 2001
  • Country
  • KWR United States
  • ANIP United States
  • Employees
  • KWR N/A
  • ANIP N/A
  • Industry
  • KWR Major Chemicals
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KWR Industrials
  • ANIP Health Care
  • Exchange
  • KWR Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • KWR 2.2B
  • ANIP 2.0B
  • IPO Year
  • KWR 1985
  • ANIP N/A
  • Fundamental
  • Price
  • KWR $135.62
  • ANIP $93.97
  • Analyst Decision
  • KWR Strong Buy
  • ANIP Strong Buy
  • Analyst Count
  • KWR 5
  • ANIP 7
  • Target Price
  • KWR $148.60
  • ANIP $99.14
  • AVG Volume (30 Days)
  • KWR 89.8K
  • ANIP 255.8K
  • Earning Date
  • KWR 10-30-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • KWR 1.52%
  • ANIP N/A
  • EPS Growth
  • KWR N/A
  • ANIP N/A
  • EPS
  • KWR N/A
  • ANIP N/A
  • Revenue
  • KWR $1,832,674,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • KWR $2.63
  • ANIP $39.51
  • Revenue Next Year
  • KWR $4.56
  • ANIP $9.58
  • P/E Ratio
  • KWR N/A
  • ANIP N/A
  • Revenue Growth
  • KWR N/A
  • ANIP 38.68
  • 52 Week Low
  • KWR $95.91
  • ANIP $52.50
  • 52 Week High
  • KWR $180.97
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • KWR 54.32
  • ANIP 57.30
  • Support Level
  • KWR $129.24
  • ANIP $93.00
  • Resistance Level
  • KWR $134.24
  • ANIP $95.94
  • Average True Range (ATR)
  • KWR 3.61
  • ANIP 2.38
  • MACD
  • KWR 0.63
  • ANIP 0.38
  • Stochastic Oscillator
  • KWR 91.85
  • ANIP 80.82

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: